Web Analytics

3 Latest Announced Rounds

  • $5,500,000
    Unknown

    6 Investors

    Financial Services
    May 1st, 2025
  • $3,750,000
    Pre Series A

    3 Investors

    E-learning Providers
    May 1st, 2025
  • $7,300,000
    Seed

    3 Investors

    Financial Services
    May 1st, 2025
$1,436.14M Raised in 58 Funding Rounds in the past 7 Days - View All

Funding Round Profile

RheumaGen

start up
United States - Denver, Colorado
  • 10/01/2025
  • Series A
  • $15,000,000

RheumaGen is a private biotechnology company engineering a new class of therapeutics to cure major autoimmune diseases at their source. RheumaGen focuses on editing the human leukocyte antigen (HLA), or “immune gene,” to develop one-time, curative cell and gene therapies. RheumaGen is headquartered in Aurora, Colorado. For more information, please visit rheumagen.com.


Related People

Richard FreedFounder

Richard Freed United States - Denver, Colorado

Co-Founder, CEO, Husband, Dad